Wiseman, OliverSmith, DaronStarr, KathAucott, LornaHernández, RodolfoThomas, RuthMaclennan, StevenClark, Charles TerryMaclennan, GraemeMcRae, DawnBell, VictoriaCotton, SeonaidhGall, ZaraTurney, BenMcClinton, Samuel2025-10-082025-08Wiseman, O, Smith, D, Starr, K, Aucott, L, Hernández, R, Thomas, R, Maclennan, S, Clark, C T, Maclennan, G, McRae, D, Bell, V, Cotton, S, Gall, Z, Turney, B & McClinton, S 2025, 'Clinical and cost-effectiveness of percutaneous nephrolithotomy, flexible ureterorenoscopy and extracorporeal shockwave lithotripsy for lower pole stones : the PUrE RCTs', Health Technology Assessment, vol. 29, no. 40. https://doi.org/10.3310/WFRE68441366-5278ORCID: /0000-0002-8316-2616/work/194125860ORCID: /0000-0002-1039-5646/work/194125901ORCID: /0000-0003-2619-8230/work/194126478ORCID: /0000-0001-6277-7972/work/194126652ORCID: /0000-0002-2691-8421/work/194127095https://hdl.handle.net/2164/26173The authors thank all the patients who participated in PUrE. A special thanks goes to the trial managers and data coordinators who helped support the study: Katie Banister, Sarah Cameron, Karen Campbell, Tracey Davidson, Alison McDonald, Jess Wood (Trial Managers), Zoe Batham, Rebecca Bruce, Dianne Dejean, and Sharon Wren (Data Co-ordinators). We thank CHaRT programming team led by Mark Forrest and other staff within CHaRT/HSRU for their assistance with PUrE: Paul Manson, Information Scientist, Samantha Wileman, Quality Assurance Manager. Thanks to Mr Rodolfo Agustín Hernández and Mr Andrés G. Hernández for retrieving HRG based unit costs for hospital interventions based on the PUrE data and following NHS costing algorithm (NHS Digital: Casemix Companion HRG+ 2020/21 and HRG+ Reference Costs Code to Group). We thank the members of the PMG for their ongoing advice and support of the trial, plus the independent members of the TSC and DMC; and the staff at the recruitment sites who facilitated the recruitment, treatment and follow-up of trial participants (all listed below). Finally, we thank the National Institute for Health Research and the Health Technology Assessment Programme for funding the PUrE study.2104578562engSDG 3 - Good Health and Well-beingR Medicine (General)Health PolicySupplementary DataDASR1Journal article10.3310/WFRE6844http://www.scopus.com/inward/record.url?scp=105013688082&partnerID=8YFLogxK